A patent review of P2X7 receptor antagonists to treat inflammatory diseases (2018 – present)

Introduction The purinergic P2×7receptor is expressed on the surface of many different types of cells, including immune cells. Targeting P2×7receptors with antagonists has been studied for its potential therapeutic effects in a variety of inflammatory illnesses. It plays a crucial role in the control of inflammatory responses.